Compare AVTX & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | PAMT |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 225.0M |
| IPO Year | 2015 | 1985 |
| Metric | AVTX | PAMT |
|---|---|---|
| Price | $15.79 | $11.21 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $32.29 | $13.00 |
| AVG Volume (30 Days) | ★ 258.0K | 24.2K |
| Earning Date | 11-06-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $192,000.00 | ★ $623,270,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.39 | $8.90 |
| 52 Week High | $20.72 | $17.29 |
| Indicator | AVTX | PAMT |
|---|---|---|
| Relative Strength Index (RSI) | 43.42 | 44.48 |
| Support Level | $14.52 | $10.91 |
| Resistance Level | $17.12 | $11.80 |
| Average True Range (ATR) | 1.23 | 0.62 |
| MACD | -0.11 | -0.18 |
| Stochastic Oscillator | 39.72 | 12.59 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.